Comparative Efficacy of Interleukin-7 and -15 Blockade in Alleviating Experimental Chronic Uveitis and Suppressing Pathogenic Memory CD4 + T Cells
Investigative Ophthalmology & Visual Science · 2025-05-05 · 66 (5) · 9
DOI: 10.1167/iovs.66.5.9 ↗At a glance
Vergleichsstudie in Investigative Ophthalmology & Visual Science, published on 2025-05-05. Written by Qiurong Zhu and 3 co-authors. Institution: Schepens Eye Research Institute of Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United Stat…. Major MEDLINE topics: Interleukin-7, CD4-Positive T-Lymphocytes, Uveitis, Interleukin-15. Cited 5 times so far (Crossref); 74 references. The full text is freely available (open access, CC BY 4.0). Funded by: NEI NIH HHS.
Abstract (original language)
Purpose
We have previously demonstrated the pathogenic function of memory CD4+ T cells, which express IL-7 receptor (IL-7R) and IL-15R, in experimental chronic autoimmune uveitis (CAU). Here, we aimed to compare the therapeutic efficacy of blocking IL-7 or IL-15 in CAU.
Methods
C57BL/6J mice were induced for CAU, then intraperitoneally injected with an anti-IL-7 antibody (Ab), an anti-IL-15 Ab, or an IgG control for 2 weeks. Disease was evaluated by weekly fundoscopy, optical coherence tomography (OCT), and full-field electroretinography for four weeks from the initiation of treatment. At week 4, retina and cervical lymph nodes (CLN) were collected for flow cytometry analysis of T-cell response.
Results
The anti-IL-7 Ab led to progressively reduced retinal infiltration and structural damage, with rapid recovery of retinal function. The anti-IL-15 Ab resulted in moderately reduced retinal infiltration and structural damage, along with a delayed, partial functional improvement. Compared to the control group, the anti-IL-7 Ab group exhibited significantly reduced disease scores from baseline on fundoscopy and OCT at week 4, and substantially improved dark-adapted (DA) a-wave and light-adapted b-wave responses at week 2; although the anti-IL-15 Ab group showed significantly improved disease from baseline only on OCT and increased DA b-waves at week 4. Both treatments effectively depleted the retinal infiltrating T cells and reduced memory Th17 cells in the CLN.
Conclusions
Our proof-of-concept study demonstrates that blocking IL-7 or IL-15 leads to specific depletion of the uveitogenic memory CD4+ T cells and disruption of disease chronicity in uveitis.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Schepens Eye Research Institute of Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States.
- Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States.
Funding
- NEI NIH HHS
Cite
APA
Zhu, Q., Shayan, M., Huckfeldt, R. M., & Chen, Y. (2025). Comparative Efficacy of Interleukin-7 and -15 Blockade in Alleviating Experimental Chronic Uveitis and Suppressing Pathogenic Memory CD4 + T Cells. Investigative Ophthalmology & Visual Science, 66(5), 9. https://doi.org/10.1167/iovs.66.5.9
Vancouver
Zhu Q, Shayan M, Huckfeldt RM, Chen Y. Comparative Efficacy of Interleukin-7 and -15 Blockade in Alleviating Experimental Chronic Uveitis and Suppressing Pathogenic Memory CD4 + T Cells. Investigative Ophthalmology & Visual Science. 2025;66(5):9. doi:10.1167/iovs.66.5.9
BibTeX
@article{Zhu2025,
author = {Zhu, Qiurong and Shayan, Maryam and Huckfeldt, Rachel M and Chen, Yihe},
title = {Comparative Efficacy of Interleukin-7 and -15 Blockade in Alleviating Experimental Chronic Uveitis and Suppressing Pathogenic Memory CD4 + T Cells},
journal = {Investigative Ophthalmology & Visual Science},
year = {2025},
volume = {66},
number = {5},
pages = {9},
doi = {10.1167/iovs.66.5.9}
}
EUVIMED